BRPI0111731C1 - suporte sólido de imunoensaio, métodos de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e de produção de um suporte sólido de imunoensaio, e, kit de teste de imunodiagnóstico - Google Patents

suporte sólido de imunoensaio, métodos de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e de produção de um suporte sólido de imunoensaio, e, kit de teste de imunodiagnóstico

Info

Publication number
BRPI0111731C1
BRPI0111731C1 BRPI0111731A BR0111731A BRPI0111731C1 BR PI0111731 C1 BRPI0111731 C1 BR PI0111731C1 BR PI0111731 A BRPI0111731 A BR PI0111731A BR 0111731 A BR0111731 A BR 0111731A BR PI0111731 C1 BRPI0111731 C1 BR PI0111731C1
Authority
BR
Brazil
Prior art keywords
immunoassay
solid
support
hcv
virus
Prior art date
Application number
BRPI0111731A
Other languages
English (en)
Other versions
BR0111731A (pt
BRPI0111731B8 (pt
BRPI0111731B1 (pt
Inventor
Medina-Selby Angelica
George-Nasciemento Carlos
Y Chien David
Coit Doris
Tandeske Laura
Arcangel Phillip
Original Assignee
Chiron Corp
Grifols Worldwide Operations Ltd
Novartis Vaccines & Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27395684&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0111731(C1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiron Corp, Grifols Worldwide Operations Ltd, Novartis Vaccines & Diagnostics Inc filed Critical Chiron Corp
Publication of BR0111731A publication Critical patent/BR0111731A/pt
Publication of BRPI0111731B1 publication Critical patent/BRPI0111731B1/pt
Publication of BRPI0111731B8 publication Critical patent/BRPI0111731B8/pt
Publication of BRPI0111731C1 publication Critical patent/BRPI0111731C1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/18—Togaviridae; Flaviviridae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/10—Detection of antigens from microorganism in sample from host
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analyzing Materials By The Use Of Magnetic Means (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

"ensaio de combinação de anticorpo/antígeno do hcv". ensaio de combinação de antígeno de núcleo de hvc anticorpo ns3/4a que pode detectar tanto antígenos de hcv quanto anticorpos presentes em uma amostra usando uma matriz sólida única, que é fornecida, bem como, suportes sólidos de imunoensaio para uso no ensaio.
BRPI0111731A 2000-06-15 2001-06-14 suporte sólido de imunoensaio, métodos de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e de produção de um suporte sólido de imunoensaio, e, kit de teste de imunodiagnóstico BRPI0111731C1 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21208200P 2000-06-15 2000-06-15
US28086701P 2001-04-02 2001-04-02
US28081101P 2001-04-02 2001-04-02
PCT/US2001/019369 WO2001096875A2 (en) 2000-06-15 2001-06-14 Hcv antigen/antibody combination assay

Publications (4)

Publication Number Publication Date
BR0111731A BR0111731A (pt) 2004-02-10
BRPI0111731B1 BRPI0111731B1 (pt) 2016-07-05
BRPI0111731B8 BRPI0111731B8 (pt) 2016-08-23
BRPI0111731C1 true BRPI0111731C1 (pt) 2021-07-27

Family

ID=27395684

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0111731A BRPI0111731C1 (pt) 2000-06-15 2001-06-14 suporte sólido de imunoensaio, métodos de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e de produção de um suporte sólido de imunoensaio, e, kit de teste de imunodiagnóstico
BRPI0111682A BRPI0111682B8 (pt) 2000-06-15 2001-06-14 suporte sólido de imunoensaio, kit de teste de imunodiagnóstico, métodos de produção de um suporte sólido de imunoensaio, e de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e, uso de um suporte sólido de imunoensaio

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0111682A BRPI0111682B8 (pt) 2000-06-15 2001-06-14 suporte sólido de imunoensaio, kit de teste de imunodiagnóstico, métodos de produção de um suporte sólido de imunoensaio, e de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e, uso de um suporte sólido de imunoensaio

Country Status (22)

Country Link
US (5) US6632601B2 (pt)
EP (2) EP1354204B2 (pt)
JP (3) JP4834279B2 (pt)
CN (3) CN1214244C (pt)
AT (2) ATE368221T1 (pt)
AU (2) AU2001272945A1 (pt)
BG (1) BG66205B1 (pt)
BR (2) BRPI0111731C1 (pt)
CA (2) CA2413003C (pt)
CY (2) CY1107537T1 (pt)
CZ (1) CZ304185B6 (pt)
DE (2) DE60125240T3 (pt)
DK (2) DK1350105T3 (pt)
ES (2) ES2277932T5 (pt)
HU (1) HU228873B1 (pt)
MX (2) MXPA02012401A (pt)
NO (1) NO332275B1 (pt)
PL (1) PL213363B1 (pt)
PT (2) PT1354204E (pt)
SI (1) SI1354204T2 (pt)
SK (1) SK287694B6 (pt)
WO (2) WO2001096875A2 (pt)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0697888B1 (en) * 1993-05-12 2003-09-17 Chiron Corporation Conserved motif of hepatitis c virus e2/ns1 region
US7491808B2 (en) * 2000-06-15 2009-02-17 Novartis Vaccines And Diagnostics, Inc. HCV non-structural protein mutants and uses thereof
BRPI0111731C1 (pt) * 2000-06-15 2021-07-27 Chiron Corp suporte sólido de imunoensaio, métodos de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e de produção de um suporte sólido de imunoensaio, e, kit de teste de imunodiagnóstico
CN100400101C (zh) * 2000-08-17 2008-07-09 特里帕普股份公司 包含病毒唑的疫苗及其使用方法
US6680059B2 (en) 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
US7022830B2 (en) 2000-08-17 2006-04-04 Tripep Ab Hepatitis C virus codon optimized non-structural NS3/4A fusion gene
US6858590B2 (en) 2000-08-17 2005-02-22 Tripep Ab Vaccines containing ribavirin and methods of use thereof
DE10106295C1 (de) * 2001-02-02 2002-08-22 Gaifar German American Inst Fo Protein mit mehreren Antigen-Epitop-Sequenzen, welches immobilisiert ist
AU785380B2 (en) * 2001-03-28 2007-03-15 Ortho-Clinical Diagnostics, Inc. A hepatitis C antigen - antibody combination assay for the early detection of HCV infection
WO2003002749A2 (en) 2001-06-26 2003-01-09 Abbott Laboratories Methods for the simultaneous detection of hcv antigens and hcv antibodies
US7101683B2 (en) 2001-06-26 2006-09-05 Abbott Laboratories Methods for the simultaneous detection of HCV antigens and HCV antibodies
US7049060B2 (en) * 2001-11-05 2006-05-23 Ortho-Clinical Diagnostics, Inc. HCV anti-core monoclonal antibodies
US7332269B2 (en) * 2001-11-11 2008-02-19 Ortho-Clinical Diagnostics, Inc. HCV core protein sequences
FR2839555B1 (fr) 2002-05-10 2007-07-27 Bio Rad Pasteur Procede de detection simultanee d'un antigene et d'un anticorps d'un microorganisme infectieux
ES2312806T3 (es) * 2002-09-09 2009-03-01 Novartis Vaccines And Diagnostics, Inc. Ensayo de vhc.
US20040152070A1 (en) * 2003-02-04 2004-08-05 Shah Dinesh O. Method of detection of HCV antibodies in combination assay or sole antibody assay
AU2004266324B8 (en) 2003-08-20 2011-04-28 Promis Neurosciences Inc. Epitope protection assay and method for detecting protein conformations
EP1799868B1 (en) * 2004-08-27 2012-01-18 Novartis Vaccines and Diagnostics, Inc. Hcv non-structural protein mutants and uses thereof
US7658930B2 (en) * 2005-02-02 2010-02-09 Peng Cui Kit for detecting the antibody of HCV and its preparing method
WO2007081447A2 (en) 2005-11-22 2007-07-19 Novartis Vaccines And Diagnostics, Inc. Norovirus and sapovirus antigens
US7794692B2 (en) * 2005-12-02 2010-09-14 Amorfix Life Sciences Ltd. Methods and compositions for detecting amyotrophic lateral sclerosis
US7887803B2 (en) 2005-12-02 2011-02-15 Amorfix Life Sciences Methods and compositions to treat misfolded-SOD1 mediated diseases
EP2514824A3 (en) 2006-03-03 2013-01-23 Amorfix Life Sciences Ltd. Methods and compositions to treat and detect misfolded-SOD1 mediated diseases
CN1908666B (zh) * 2006-08-14 2010-05-12 武汉大学 一种检测乙肝核心抗体的双夹心法酶联免疫诊断试剂盒及应用
WO2009022236A2 (en) 2007-08-16 2009-02-19 Tripep Ab Immunogen platform
CN102378914B (zh) * 2009-03-30 2014-12-10 生物梅里埃公司 用于hcv检测的固体支持物
US20100297607A1 (en) * 2009-05-20 2010-11-25 Jian Zheng Reagents For HCV Antigen-Antibody Combination Assays
US9744228B2 (en) 2010-04-07 2017-08-29 Norvartis Ag Method for generating a parvovirus B19 virus-like particle
WO2011158174A1 (en) * 2010-06-17 2011-12-22 Koninklijke Philips Electronics N.V. Multi epitope assay
CA2804501C (en) 2010-07-06 2021-01-26 Novartis Ag Noro virus derived immunogenic compositions and methods
US20120009196A1 (en) * 2010-07-08 2012-01-12 Abbott Laboratories Monoclonal antibodies against hepatitis c virus core protein
JP5911889B2 (ja) * 2011-01-13 2016-04-27 オーソ−クリニカル・ダイアグノスティックス・インコーポレイテッドＯｒｔｈｏ−Ｃｌｉｎｉｃａｌ Ｄｉａｇｎｏｓｔｉｃｓ， Ｉｎｃ． 梅毒トレポネーマトリプレット抗原
FR2984328B1 (fr) 2011-12-20 2016-12-30 Bio-Rad Innovations Procede de detection d'une infection par le virus de l'hepatite c
CN105378099B (zh) 2013-03-14 2021-05-11 雅培制药有限公司 Hcv核心脂质结合结构域单克隆抗体
WO2014143342A1 (en) 2013-03-14 2014-09-18 Abbott Laboratories Hcv ns3 recombinant antigens and mutants thereof for improved antibody detection
MX362075B (es) 2013-03-14 2019-01-07 Abbott Lab Ensayo de combinación de antígeno-anticuerpo del virus de la hepatitis c (vhc) y métodos y composiciones para usarlo.
CN103630690B (zh) * 2013-12-17 2014-08-20 朱之炜 丙型肝炎病毒抗原抗体联合检测试剂盒及其检测方法
ES2832335T3 (es) 2015-03-27 2021-06-10 Ortho Clinical Diagnostics Inc Polipéptidos NS4A/NS3 modificado del VHC y usos de los mismos
US20180292408A1 (en) * 2015-04-20 2018-10-11 Qoolabs, Inc. Camelid single-domain hcv antibodies and methods of use
CN111164221B (zh) * 2017-09-27 2024-03-29 生物辐射实验室股份有限公司 数字化亲和连接试验
CN110261616B (zh) * 2019-04-30 2021-07-20 广东菲鹏生物有限公司 一种丙型肝炎病毒检测试剂盒
CA3224156A1 (en) 2021-06-28 2023-01-05 VST LLC dba Medgene Labs Sapovirus vaccines
CN115057943B (zh) * 2022-06-22 2025-03-14 杭州水芭莎生物医药科技有限公司 一种抗菌肽融合蛋白及其制备方法和应用
CN115838420B (zh) * 2022-10-31 2023-05-05 北京科跃中楷生物技术有限公司 一种可溶性hcv重组蛋白的制备方法及其制备的抗体检测试剂

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350671A (en) 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
YU48038B (sh) * 1987-11-18 1996-10-18 Chiron Corp. Postupak za dijagnostiku ne-a, ne-v hepatitisa
WO1989004669A1 (en) * 1987-11-18 1989-06-01 Chiron Corporation Nanbv diagnostics and vaccines
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
JP2730153B2 (ja) 1989-03-16 1998-03-25 日本合成ゴム株式会社 熱可塑性樹脂組成物およびその製造方法
HUT54896A (en) * 1989-03-17 1991-04-29 Chiron Corp Process for producing aquous diagnosticum and vaccine of nanbv
WO1990014436A1 (en) * 1989-05-18 1990-11-29 Chiron Corporation Nanbv diagnostics: polynucleotides useful for screening for hepatitis c virus
US6194140B1 (en) * 1990-04-04 2001-02-27 Chiron Corporation HCV NS3 protein fragments having helicase activity and improved solubility
US5712087A (en) 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
KR100206150B1 (ko) 1990-04-04 1999-07-01 로버트 피. 블랙버언 항-에이치씨브이 항체에 대한 면역분석용 씨형 간염 바이러스(에이치디브이)항원의 조합체
CA2049679C (en) 1990-08-24 2005-06-21 Sushil G. Devare Hepatitis c assay utilizing recombinant antigens
PT97247B (pt) * 1991-04-03 1997-10-31 Chiron Corp Processo de preparacao de combinacoes de antigenios do virus da hepapite c (hcv) para uso em imunoensaios para anticorpos anti-hcv
KR0185426B1 (ko) 1991-06-24 1999-04-01 로버트 피. 블랙버언 씨형 간염 바이러스 폴리펩티드
UA39944C2 (uk) * 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
US6762024B2 (en) * 1993-04-27 2004-07-13 Innogenetics, S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
JP3217600B2 (ja) 1994-07-12 2001-10-09 株式会社先端生命科学研究所 非ａ非ｂ型肝炎ウイルス関連抗原のイムノアッセイ、それに使用するモノクローナル抗体、およびこの抗体を産生するハイブリドーマ
DE4428705A1 (de) * 1994-08-12 1996-02-15 Boehringer Mannheim Gmbh Rekombinantes Antigen aus der NS3-Region des Hepatitis C Virus
US5843752A (en) 1995-05-12 1998-12-01 Schering Corporation Soluble active hepatitis C virus protease
US5990276A (en) 1996-05-10 1999-11-23 Schering Corporation Synthetic inhibitors of hepatitis C virus NS3 protease
US6514731B1 (en) * 1996-05-24 2003-02-04 Chiron Corporation Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens
DK0935662T3 (da) * 1996-05-24 2006-03-06 Chiron Corp Fusionsprotein med multiple epitoper
US6322965B1 (en) * 1997-02-10 2001-11-27 Advanced Life Science Institute, Inc. Chimera antigen peptide
CA2303123C (en) * 1997-09-22 2006-04-11 Chiron Corporation Method for detecting antibodies in a sample
ATE412904T1 (de) * 1998-07-30 2008-11-15 Advanced Life Science Inst Inc Verfahren zur bestimmung von hepatitis c viren
BRPI0111731C1 (pt) * 2000-06-15 2021-07-27 Chiron Corp suporte sólido de imunoensaio, métodos de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e de produção de um suporte sólido de imunoensaio, e, kit de teste de imunodiagnóstico

Also Published As

Publication number Publication date
JP2011125350A (ja) 2011-06-30
SK17772002A3 (sk) 2003-10-07
SK287694B6 (sk) 2011-06-06
EP1354204A2 (en) 2003-10-22
CZ304185B6 (cs) 2013-12-11
DE60129598D1 (de) 2007-09-06
US20040096822A1 (en) 2004-05-20
CN1256591C (zh) 2006-05-17
PL365599A1 (en) 2005-01-10
US7241879B2 (en) 2007-07-10
CZ20024058A3 (cs) 2003-09-17
EP1354204B2 (en) 2010-04-21
US20040265801A1 (en) 2004-12-30
DE60125240T3 (de) 2010-10-28
BR0111731A (pt) 2004-02-10
DK1354204T4 (da) 2010-06-14
MXPA02012401A (es) 2003-04-25
CN1660913A (zh) 2005-08-31
BR0111682A (pt) 2004-01-06
NO20025878D0 (no) 2002-12-06
CA2413003A1 (en) 2001-12-20
BRPI0111682B8 (pt) 2021-07-27
US20040063092A1 (en) 2004-04-01
CY1106820T1 (el) 2012-05-23
WO2001096875A9 (en) 2002-08-15
HUP0500444A3 (en) 2010-03-29
ES2288969T3 (es) 2008-02-01
DE60125240D1 (de) 2007-01-25
DK1350105T3 (da) 2007-11-12
CN1489692A (zh) 2004-04-14
DE60125240T2 (de) 2007-07-12
CN100463922C (zh) 2009-02-25
BG107441A (bg) 2004-01-30
BRPI0111682B1 (pt) 2017-09-19
WO2001096870A3 (en) 2003-07-31
US20020146685A1 (en) 2002-10-10
WO2001096870A2 (en) 2001-12-20
EP1354204B1 (en) 2006-12-13
HU228873B1 (hu) 2013-06-28
DE60129598T2 (de) 2008-04-17
MXPA02012424A (es) 2003-04-25
SI1354204T1 (sl) 2007-04-30
EP1350105B1 (en) 2007-07-25
CY1107537T1 (el) 2013-03-13
CA2412035C (en) 2012-04-10
CA2413003C (en) 2013-08-13
HUP0500444A2 (hu) 2005-08-29
US6630298B2 (en) 2003-10-07
ATE348337T1 (de) 2007-01-15
AU2001272945A1 (en) 2001-12-24
BRPI0111731B8 (pt) 2016-08-23
CA2412035A1 (en) 2001-12-20
NO332275B1 (no) 2012-08-13
HK1079796A1 (en) 2006-04-13
US6797809B2 (en) 2004-09-28
ATE368221T1 (de) 2007-08-15
WO2001096875A2 (en) 2001-12-20
PL213363B1 (pl) 2013-02-28
PT1350105E (pt) 2007-08-13
US20020192639A1 (en) 2002-12-19
ES2277932T5 (es) 2010-06-28
PT1354204E (pt) 2007-03-30
HK1061861A1 (en) 2004-10-08
US7319144B2 (en) 2008-01-15
NO20025878L (no) 2003-02-12
DK1354204T3 (da) 2007-04-10
US6632601B2 (en) 2003-10-14
EP1350105A2 (en) 2003-10-08
BRPI0111731B1 (pt) 2016-07-05
JP2004506878A (ja) 2004-03-04
BG66205B1 (bg) 2012-01-31
ES2277932T3 (es) 2007-08-01
WO2001096875A3 (en) 2003-08-28
JP2004510133A (ja) 2004-04-02
SI1354204T2 (sl) 2010-09-30
CN1466682A (zh) 2004-01-07
CN1214244C (zh) 2005-08-10
AU2001272948A1 (en) 2001-12-24
JP4837229B2 (ja) 2011-12-14
JP4834279B2 (ja) 2011-12-14

Similar Documents

Publication Publication Date Title
BRPI0111731B8 (pt) suporte sólido de imunoensaio, métodos de detecção de infecção pelo vírus da hepatite c (hcv) em uma amostra biológica, e de produção de um suporte sólido de imunoensaio, e, kit de teste de imunodiagnóstico
ATE303597T1 (de) Hcv mosaik antigen zusammensetzung
AR033448A1 (es) Prueba de combinacion antigeno-anticuerpo para hepatitis c para una deteccion temprana de la infeccion
DE69819643D1 (de) Zwei-Inkubations mit markiertem Antigen verwendenes Immunoassay
BR0314166B8 (pt) teste de hcv
CY1106349T1 (el) Συστηματα ανιχνευσης ανοσοπροσδιορισμου ιικου αντιγονου ηπατιτιδας c
CA2515084A1 (en) Improved method of detection of hcv antibodies in combination assay or sole antibody assay
TW200722527A (en) Methods of detecting hepatitis C virus
DK1192469T3 (da) Assay
WANG et al. Preparation and testing of hepatitis C core antigen ELISA reagent
Lee et al. Development of a Rapid Point of Care Test for the Diagnosis of Hepatitis C Infection
BR0206887A (pt) Reagentes para a detecção simult nea de antìgenos e anticorpos de núcleo de do vìrus da hepatite c (hcv)
ES2178517B1 (es) Procedimiento para el estudio de la activacion funcional de leucocitos, plaquetas y otras celulas.
Smith A Brief Update on Rabbit Hemorrhagic Disease Virus
RU93051201A (ru) Способ выявления антигена вируса гепатита е
UY26379A1 (es) Ensayo inmunoenzimático ligado a enzimas de inhibición (ielisa) para la detección y cuantificación de anticuerpos en muestras biológicas
AR047524A1 (es) Ensayo de prion de cjd
NO931613L (no) Fremgangsmaate for bestemming av sensiteten og/eller det spesifikke ved et proberingssystem for sporing av antistoffer

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US)

Free format text: ALTERADO DE: CHIRON CORPORATION

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]

Free format text: NOTIFICACAO DE DEVOLUCAO DO PEDIDO POR NAO SE ENQUADRAR NO ART. 229-C DA LPI.

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B25C Requirement related to requested transfer of rights

Owner name: NOVARTIS VACCINES AND DIAGNOSTICS, INC. (US)

Free format text: A FIM DE ATENDER A TRANSFERENCIA, REQUERIDA ATRAVES DA PETICAO NO 20140016886/RJ DE 09/05/2014, E NECESSARIO APRESENTAR O DOCUMENTO DE CESSAO COM A DEVIDA LEGALIZACAO CONSULAR.

B25A Requested transfer of rights approved

Owner name: GRIFOLS WORLDWIDE OPERATIONS LIMITED (IE)

B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/07/2016, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REFERENTE A RPI 2374 DE 05/07/2016, QUANTO AO NOME DO INVENTOR.

B25G Requested change of headquarter approved
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 14/06/2001, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B21H Decision of lapse of a patent or of a certificate of addition of invention cancelled [chapter 21.8 patent gazette]

Free format text: ANULADA A PUBLICACAO CODIGO 21.6 NA RPI NO 2674 DE 05/04/2022, POR TER SIDO INDEVIDA, EM VIRTUDE DO DESPACHO 16.3 PUBLICADO NA RPI 2638, DE 27/07/2021.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 14/06/2021